Notícias · Recifes

Researchers reveal immune mechanisms that drive development of rare allergic stomach disea

Researchers at Tel Aviv University have developed one of the first experimental models that faithfully reproduces eosinophilic gastritis (EoG), a rare but increasingly recognized allergic disease of the stomach. Using this model, they identified the immune pathways responsible fo

Admin Recifes 15/07/2026 2

Long COVID patients are told symptoms are in their head—here's how to change the narrative

Between us, we bring two perspectives to persistent illness: personal experience of long COVID and clinical and research experience in chronic illness rehabilitation.

Admin Recifes 15/07/2026 3

Ibuprofen safely dampens inflammatory markers in 28-patient drug-resistant tuberculosis tr

The Experimental Tuberculosis Unit (UTE) at the Germans Trias i Pujol Research Institute (IGTP) has published in Nature Communications the results of a phase IIa pilot clinical trial assessing ibuprofen as a host-directed therapy in patients with pre-extensively drug-resistant tu

Admin Recifes 15/07/2026 2

Eating an avocado a day lowers heart disease risk factor for people with obesity

Eating an avocado every day may decrease heart disease risk in adults with obesity, according to a recent study led by researchers in the Penn State Department of Nutritional Sciences and published in the Journal of Clinical Lipidology.

Admin Recifes 15/07/2026 2

Can AI help make medical records less biased? New study suggests yes—with caveats

Large language models can identify judgmental language in clinical notes, but the settings play a major role in accuracy.

Admin Recifes 15/07/2026 2

Trial finds combined exercise-nutrition intervention safe but not more effective in ICU

A new national clinical trial is helping reshape the future of recovery research for critically ill patients, providing important new evidence about how rehabilitation and nutrition interventions should be delivered during severe illness and informing the next generation of resea

Admin Recifes 15/07/2026 2

Cannabis-derived treatment eases agitation in hospice-eligible dementia patients, trial fi

In a first-of-its-kind clinical trial, U.S. researchers found that people with agitation and dementia in late life who took a special medical formulation of two active ingredients found in marijuana—THC and CBD—had significantly less agitation than people who received a placebo.

Admin Recifes 15/07/2026 3

Amyloid-clearing treatment may curb tau buildup for years in Alzheimer's brain

An analysis of the brain of a deceased Alzheimer's disease (AD) clinical trial participant found that regions where an anti-amyloid therapy successfully cleared amyloid plaques showed little to no evidence of tau tangles, a hallmark of AD closely linked to neurodegeneration and c

Admin Recifes 15/07/2026 2

Alcohol intoxication, stress in adolescence linked with long-term impairments

Repeated alcohol intoxication or exposure to stress appears to change how adolescent brains respond to danger. These changes persist into adulthood. In a study published in Alcohol: Clinical and Experimental Research, adolescent mice repeatedly exposed to alcohol or stress were l

Admin Recifes 15/07/2026 2

Genetically engineered Bifidobacterium shows potential for oral delivery of cancer vaccine

A novel oral vaccine platform using genetically engineered Bifidobacterium could enhance anti-tumor immunity. In an exploratory Phase I clinical study, the vaccine was well tolerated and generated immunologic and clinical findings that warrant further investigation. The results a

Admin Recifes 15/07/2026 2

Immunotherapy shows long-term promise in aggressive lymphoma

A leading-edge immunotherapy may extend survival for patients with one of the most aggressive forms of blood cancer, according to newly published five-year results from a major clinical trial in the Blood Journal. The clinical trial evaluated lisocabtagene maraleucel (liso-cel),

Admin Recifes 15/07/2026 2

Trial of potential Ebola antiviral under way: WHO

The first clinical trial of an antiviral drug's effectiveness in people exposed to the deadly Ebola strain spreading in the Democratic Republic of Congo is underway, the WHO said Tuesday.

Admin Recifes 15/07/2026 2

Acompanhe as Notícias da Recifes